AMPAC Fine Chemicals (AFC), a leading US-based contract development and manufacturing organisation (CDMO) has announced its sale to SK Holdings, an investment holding company of SK Group (South Korea).
US$133 million deal adds European Early Development Center of Excellence to global network
“Fail early and fail cheap” – this was the key message from Dr Magid Abou-Gharbia of the Moulder Center for Drug Discovery Research at Temple University’s School of Pharmacy in Philadelphia, US.
Winners will be announced live at the Gala Ceremony in Madrid at CPhI Worldwide with over 500 of Pharma’s top executives
Much needed more efficient manufacturing processes aren’t being completed by pharma for ADCs
The Bill & Melinda Gates Foundation and the UK Government’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) have joined the CARB-X partnership, which supports global scientific research to develop new vaccines, preventatives and other products against drug-resistant bacterial infecti
Ministers of the European Parliament have called for an end to cosmetics animal testing and urged the EU to launch a ‘diplomatic drive’ for a worldwide ban before 2023.
DuPont Industrial Biosciences and Archer Daniels Midland Company (ADM) have opened the world’s first biobased furan dicarboxylic methyl ester (FDME) pilot production facility in Decatur, Illinois, US.
EU member states have voted to impose a near- total ban on neonicotinoid insecticides – the most widely used class of insecticides in the world – across the region. The ban will cover all crops grown outdoors, but growers will still be free to use them in greenhouses across the EU.
Current Issue
AMPAC Fine Chemicals (AFC), a leading US-based contract development and manufacturing organisation (CDMO) h
US$133 million deal adds European Early Development Center of Excellence to global network
“Fail early and fail cheap” – this was the key message from Dr Magid Abou-Gharbia of the Moulder Center for
Winners will be announced live at the Gala Ceremony in Madrid at CPhI Worldwide with over 500 of Pharma’s top executives
Most Popular
Agrichemical giant Bayer has won EU antitrust approval for its US$62.5 billion acquisition of Monsanto, Reuters reports, on condition that Bayer sells off substantial parts of its business. If the merger goes ahead, it would create a company with control of more than a quarter of the world’s seed and pesticides market.
Chemicals company Evonik and electronics giant Siemens have launched a joint research project to convert carbon dioxide (CO2) into speciality chemicals, using electricity from renewable sources and bacteria.
Paints, coatings and speciality chemicals multinational AkzoNobel has announced the sale of its entire speciality chemicals business to The Carlyle Group and Singaporean investment fund GIC for €10.1 billion (US$12.3 billion). The sale is expected to be complete by the end of the year.
In a press release, the company said a private sale would be in the best interests of AkzoNobel and its stakeholders. The Carlyle Group has a global presence and the financial capacity to enable the speciality chemicals business to achieve its full potential.
